Literature DB >> 3731665

Reduction of paracetamol and aspirin metabolism during viral hepatitis.

C Jorup-Rönström, B Beermann, E Wåhlin-Boll, A Melander, S Britton.   

Abstract

The single-dose pharmacokinetics of two analgesic drugs, paracetamol (acetaminophen) and aspirin, were studied in healthy volunteers and in patients with viral hepatitis during the acute and the convalescent phase. Impaired elimination of paracetamol and aspirin was found in hepatitis patients, while plasma peak concentrations were unaffected. Recovered patients were not different from healthy controls in the rate of drug elimination. The data suggest normal single dosage for these drugs in acute viral hepatitis, and dosage modification only in severe cases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731665     DOI: 10.2165/00003088-198611030-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  37 in total

1.  Effect of acute viral hepatitis in man on the disposition and elimination of meperidine.

Authors:  T S McHorse; G R Wilkinson; R F Johnson; S Schenker
Journal:  Gastroenterology       Date:  1975-04       Impact factor: 22.682

2.  Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy.

Authors:  J R Mitchell; S S Thorgeirsson; W Z Potter; D J Jollow; H Keiser
Journal:  Clin Pharmacol Ther       Date:  1974-10       Impact factor: 6.875

3.  Salicylate accumulation kinetics in man.

Authors:  G Levy; T Tsuchiya
Journal:  N Engl J Med       Date:  1972-08-31       Impact factor: 91.245

4.  Elimination of paracetamol in chronic liver disease.

Authors:  R Arnman; R Olsson
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1978-08

5.  [Determination of human liver cytochrome P-450 by a micromethod using the electron paramagnetic resonance. Study of 141 liver biopsies (author's transl)].

Authors:  L Gabrielle; F Leterrier; C Molinié; H Essioux; P Cristau; C Laverdant
Journal:  Gastroenterol Clin Biol       Date:  1977-10

6.  Paracetamol metabolism in chronic liver disease.

Authors:  J A Forrest; P Adriaenssens; N D Finlayson; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1979-07       Impact factor: 2.953

7.  Influence of acute viral hepatitis on disposition and pharmacologic effect of warfarin.

Authors:  R L Williams; W L Schary; T F Blaschke; P J Meffin; K L Melmon; M Rowland
Journal:  Clin Pharmacol Ther       Date:  1976-07       Impact factor: 6.875

8.  The effect of salicylates on the hemostatic properties of platelets in man.

Authors:  H J Weiss; L M Aledort; S Kochwa
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

9.  Pharmacokinetics and metabolism of theophylline in patients with liver diseases.

Authors:  A H Staib; D Schuppan; R Lissner; W Zilly; G von Bomhard; E Richter
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-11

10.  [Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure].

Authors:  J Belaieff; B Cochet; A F Allaz; M Rudhardt; L Balant; J Fabre
Journal:  Schweiz Med Wochenschr       Date:  1981-04-04
View more
  6 in total

Review 1.  Guide to drug dosage in hepatic disease.

Authors:  N M Bass; R L Williams
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

Review 2.  Dengue and its effects on liver.

Authors:  Jayanta Samanta; Vishal Sharma
Journal:  World J Clin Cases       Date:  2015-02-16       Impact factor: 1.337

Review 3.  Can paracetamol (acetaminophen) be administered to patients with liver impairment?

Authors:  Kelly L Hayward; Elizabeth E Powell; Katharine M Irvine; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

Review 4.  Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors.

Authors:  H K Kroemer; U Klotz
Journal:  Clin Pharmacokinet       Date:  1992-10       Impact factor: 6.447

5.  Analgesics in patients with hepatic impairment: pharmacology and clinical implications.

Authors:  Marija Bosilkovska; Bernhard Walder; Marie Besson; Youssef Daali; Jules Desmeules
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

Review 6.  Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature.

Authors:  Thomas M Caparrotta; Daniel J Antoine; James W Dear
Journal:  Eur J Clin Pharmacol       Date:  2017-10-24       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.